Dosing & Administration

Portable on-demand therapy with subcutaneous dosing

FIRAZYR (icatibant) is indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older.1

As the only prefilled, self-administered, subcutaneous injection to treat acute HAE attacks, FIRAZYR is ready to use as soon as patients feel attack symptoms—no mixing, special handling, or refrigeration needed.1

  • FIRAZYR is administered over at least 30 seconds into the abdominal area.1
  • Patients may self-administer FIRAZYR upon recognition of symptoms of an HAE attack, after training by a healthcare professional.1
  • FIRAZYR is available as a 3-mL, prefilled, single-use syringe (30 mg).1
    • Requires no reconstitution, no dose calculation, no dose titration, and no refrigeration
  • If response is inadequate or symptoms recur, additional doses may be administered at intervals of 6 hours or longer.1
    • No more than 3 doses may be used in a 24-hour period
  • FIRAZYR is available in a convenient 3-pack. One-pack refills are also available.1

FIRAZYR® (icatibant injection) product packaging photo